# Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction

> **NCT00050362** · PHASE2 · COMPLETED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 136 (—)

## Conditions studied

- Pain
- Tooth Extraction

## Interventions

- **DRUG:** Rofecoxib and Bupivacaine

## Key facts

- **NCT ID:** NCT00050362
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 136 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050362, "Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00050362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*